top of page

SCIENTIFIC EVENTS ORGANISATION

Conferences

​

Scientific events organisation.jpg

Conference sessions

Oral presentations Mathieu Vinken.jpg

Workshops and

courses

Mathieu Vinken Workshops.jpg.png

Seminars and webinars

Mathieu Vinken Seminars and Webinars.jpg
Conferences

(Co-)organisation of conferences

  • 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • International Gap Junction Conference, Ghent-Belgium, 06-11/08/2011.

  • 17th Conference of the European Society for Toxicology In Vitro, Lisbon-Portugal, 16-19/10/2012.

  • 18th Conference of the European Society for Toxicology In Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • 19th Conference of the European Society for Toxicology In Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • 20th Conference of the European Society for Toxicology In Vitro, Berlin-Germany, 15-18/10/2018.

  • 8th Annual Meeting of the ASCCT: Computational toxicology: peeking into the clouds while keeping our feet on solid ground”, Gaithersburg-USA, 25-26/09/2019.

  • International Industrial and Environmental Toxicology Congress, Antalya-Turkey, 26-29/10/2019.

  • BelTox/IC-3Rs/INVITROM joint symposium, Brussels-Belgium, 21-22/11/2019. 

  • 11th Virtual World Congress on Alternatives and Animal Use in the Life Sciences, 23/08-02/09/2021.

  • 55th Congress of the European Societies of Toxicology, Virtual Conference, 27/09-01/10/2021.

  • International Colloquium on Gap Junctions and Cancer, Sao Paulo-Brazil, 10-14/07/2023.

  • 12th World Congress on Alternatives and Animal Use in the Life Sciences, Niagara Falls-Canada, 27-31/08/2023.

  • 57th Congress of the European Societies of Toxicology, Ljubljana-Slovenia, 10-13/09/2023.

  • 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • 5th Latin American Congress of Alternative Methods to the Use of Experimental Animals, Bogota-Colombia, 16-20/09/2024.

  • Microphysiological World Summit 2025, Brussels-Belgium, 09-13/06/2025.

  • 13th World Congress on Alternatives and Animal Use in the Life Sciences, Rio de Janeiro-Brazil, 31/08-04/09/2025.

Sessions

Organisation of conference sessions

  • “Metabolism and toxicokinetics”, 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • “Epigenetics”, 8th World Congress on Alternatives and Animal Use in the Life Sciences, Montréal-Canada, 21-25/08/2011.

  • “Carcinogenicity testing” and “Student session”, 17th Conference of the European Society for Toxicology in Vitro, Lisbon-Portugal, 16-19/10/2012.

  • “Connexin-based cellular signalling and its relevance to toxicology”, 49th Conference of the European Societies of Toxicology, Interlaken-Switzerland, 01-04/09/2013.

  • “New molecular biotechnology in toxicology” and “Job opportunity and career exploration”, 18th Conference of the European Society for Toxicology in Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • “Pathway approaches in toxicology”, 9th World Congress on Alternatives and Animal Use in the Life Sciences, Prague-Czech Republic, 24-28/08/2014.

  • “The role of connexin-based channels in toxicity”, Society of Toxicology Meeting, San Diego-USA, 22-26/03/2015.

  • “Regulation and traffic of hemichannels and gap junction channels”, International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • “Implementation of the adverse outcome pathway in HeMiBio”, SEURAT Symposium “Painting the future animal-free safety assessment of chemical substances: achievements of SEURAT-1”, Brussels-Belgium, 04/12/2015.

  • “Systemic toxicity” and “Job opportunity and career exploration”, 19th Conference of the European Society for Toxicology in Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • “Predicting drug-induced cholestatic injury in humans”, Society of Toxicology Meeting, San Antonio-USA, 11-15/03/2017.

  • “Job opportunity and career exploration”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “Biomarkers in predictive toxicology and risk assessment”, 55th Congress of the European Societies of Toxicology, Helsinki-Finland, 08-11/09/2019.

  • "Emerging tools for the investigation and prediction of liver toxicity”, 57th Congress of the European Societies of Toxicology (Virtual Conference), 27/09-01/10/2021.

  • "Mechanistic toxicology as the basis for modelling and prediction of organ-specific toxicity”, 57th Congress of the European Societies of Toxicology (Virtual Conference), 27/09-01/10/2021.

  • “Next generation risk assessment of chemicals”, ILSI Europe Annual Symposium (virtual event), 05/10/2021.

  • “Onward and upward as an early career scientist”, ILSI Europe Annual Symposium (virtual event), 05/10/2021.

  • “Roundtable discussion: implementation and use of in silico tools for toxicity testing: academic, industrial and regulatory perspectives”, XVIth International Congress of Toxicology, Maastricht-The Netherlands, 18-21/09/2022.

  • "Organ-specific toxic pathways: recent progress in drug-induced adversities", 11th Congress of the Turkish Society of Toxicology, Antalya-Turkey, 02-05/11/2022.

  • "Challenges in the development of generic PBK models for next generation risk assessment”, Society of Toxicology Meeting, Nashville-USA, 19-23/03/2023.

  • "ASPIS: from molecular toxicology to regulatory acceptance: the next steps for animal-free testing”, 12th World Congress on Alternatives and Animal Use in the Life Sciences, Niagara Falls-Canada, 27-31/08/2023.

  • "Acceptance and use of in vitro methods: a perspective from various chemical sectors", 57th Congress of the European Societies of Toxicology, Ljubljana-Slovenia, 10-13/09/2023.

  • "Space nutrition: an inspiration for innovation", ILSI Europe Annual Symposium, Brussels-Belgium, 24-25/10/2023.

  • "New developments in micro- and nanoplastics research", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Young scientist session: emerging researchers in the field of in vitro and in silico toxicology", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "PFAS and health: state-of-the-art in some areas of controversy", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Microphysiological systems as emerging tools in predictive toxicology", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

Workshop and courses

Organisation of workshops, symposia and courses

  • Workshop “In vivo extrapolation of in vitro data in toxicology: state-of-the-art and challenges”, Lisbon-Portugal, 20/10/2012.

  • HeMiBio winterschool “Concepts of toxicology and risk assessment”, Barcelona-Spain, 16/01/2013.

  • HeMiBio summerschool “Practical concepts of in vitro and in silico toxicology”, Brussels-Belgium, 04-06/06/2013.

  • 4th ECS workshop “Ca2+ and cell death”, Leuven-Belgium, 11-13/09/2013.

  • SEURAT summerschool, Egmond aan zee-The Netherlands, 07-09/06/2014.

  • HeMiBio winterschool “In vitro biokinetics”, 13/01/2015, Chur-Switzerland.

  • “Applied in vitro toxicology course”, Lisbon-Portugal, 25-29/01/2015.

  • HeMiBio International Symposium “Biology meets technology for liver toxicity testing”, Leuven-Belgium, 02-03/12/2015.

  • “Applied in vitro toxicology course”, Brasilia-Brazil, 20-24/06/2016.

  • “Science Xpression” workshop, La Coruna-Spain, 26-28/09/2016.

  • “Applied in vitro toxicology course”, Belvaux-Luxembourg, 08-13/01/2017.

  • “AOP light course”, Leuven-Belgium, 25/06/2017.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 25-29/09/2017.

  • “Applied in vitro toxicology course”, Utrecht-The Netherlands, 08-13/04/2018.

  • Continuing Education Course “Organ-specific in vitro modelling: state-of-the-art”, 54th Congress of the European Societies of Toxicology, Brussels-Belgium, 02-05/09/2018.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 24-28/09/2018.

  • Workshop “AOP: an essential tool in in vitro toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • Workshop “Hands-on training in vitro and in silico toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “ILSI workshop: use of AOPs in safety evaluation of food additives”, Brussels-Belgium, 26-27/02/2019.

  • “Applied in vitro toxicology course”, Bucharest-Romania, 14-19/04/2019.

  • “Molecular Toxicology Course”, Izmir-Turkey, 26-29/06/2019.

  • “Science Xpression” workshop, La Coruna-Spain, 07-11/10/2019.

  • “PANACHE Science Xpression online workshop”, 06-07/10/2020.

  • “Applied in vitro toxicology course”, Brussels-Belgium, 25-30/10/2020.

  • "ONTOX-VHP4 Safety workshop", Utrecht-The Netherlands, 19/10/2022.

  • "ASPIS NGRA framework online workshop", 27/10/2022.

  • “ASPIS open symposium”, Sitges-Spain, 24-25/11/2022.

  • “ASPIS open symposium”, Ljubljana-Slovenia, 14-15/09/2023.

  • “Cholestatic liver disorders: from bed to benchside”, Leuven-Belgium, 21-22/09/2023.

  • "10th ECS workshop: the Ca2+ signaling toolkit in health and disease”, Leuven-Belgium, 15-17/11/2023.

  • ONTOX Hackathon "Hack to save lives and avoid animal suffering", Utrecht-The Netherlands, 21-23/04/2024.

  • ONTOX-VHP4Safety joint meeting, Utrecht-The Netherlands, 26/04/2024.

  • “2nd Molecular Toxicology Course”, Izmir-Turkey, 22-24/05/2024.

  • "ILSI Europe training "Advancements in toxicological hazard and risk assessment for food safety: exploring new approach methodologies and predictive models", Brussels-Belgium, 28/05-29/08/2024.

Seminars and webinars

Organisation of seminars and webinars

  • Seminar “Mechanisms of cholestatic liver injury: from animal models to humans”, Brussels-Belgium, 06/09/2018.

  • ASCCT/ESTIV webinar “Stem cell-based in vitro models: state-of-the-art tools to predict drug-induced tissue injury in humans”, 23/10/2018.

  • ASCCT/ESTIV webinars “Pairwise toxicity evaluation of ceramic nanoparticles exposure in human alveolar epithelial A549 cells at submerged and air-liquid cultures” and “Reproducible in vitro toxicology testing using functional immortalized cells”, 23/01/2019.

  • ASCCT/ESTIV webinars “Developing mechanism-based animal toxicity models: a chemocentric approach using big data” and “Integrating genomics and epigenomics into predictive toxicology of the AH receptor”, 20/02/2019.

  • ASCCT/ESTIV webinars “Efficient functional cyst formation of biliary epithelial cells using microwells for potential bile duct organisation in vitro” and “Generation of recombinant human anti-diphtheria toxin neutralizing antibody to replace equine sera”, 20/03/2019.

  • ASCCT/ESTIV webinar “Automated and integrated analysis workflow for adverse outcome pathway identification, hypothesis generation and risk assessment”, 25/04/2019.

  • ASCCT/ESTIV webinar “New computational tools from EPA: the CompTox chemicals dashboard and generalized read-across”, 09/05/2019.

  • ASCCT/ESTIV webinar “GARD™air: an in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning”, 12/06/2019.

  • Applied In Vitro Toxicology Roundtable discussion “Mitochondrial toxicity”, 20/08/2019.

  • ASCCT/ESTIV webinar “Developmental neurotoxicity evaluation: on the road to regulatory acceptance”, 28/08/2019.

  • ASCCT/ESTIV webinar “Nerve-on-a-chip platform for assessing chemotherapy-induced peripheral neuropathy”, 17/09/2019.

  • ASCCT/ESTIV webinar “Translational challenges in in vitro nephrotoxicity models”, 22/10/2019.

  • ASCCT/ESTIV webinar “The pros and cons of 3D in vitro cultures of liver fibrosis”, 04/11/2019.

  • ASCCT/ESTIV webinar “Deep learning in toxicity prediction: reasons for use and possible applications”, 04/12/2019.

  • ASCCT/ESTIV webinars “Role of in vitro mechanistic data for the assessment of endocrine disruptors in the regulatory context” and “A battery of animal-free in vitro assays for evaluating prenatal developmental toxicity potency of highly complex petroleum substances”, 21/01/2020.

  • ASCCT/ESTIV webinar “Moving away from animal testing for acute inhalation toxicity testing”, 25/02/2020.

  • ASCCT/ESTIV webinars “Toxicological mechanistic inference: generating mechanistic explanations of adverse outcomes” and “co-expression network analysis to identify heterogeneity between the breast cancer cell line MCF-7 and human breast cancer tissues”, 11/03/2020.

  • AlterTox Academy webinar "Secrets for winning a grant and coping when losing it", 11/09/2020.

  • EUROTOX in vitro and in silico specialty section webinar "Role of in vitro and in silico methodologies in COVID-19 research", 17/09/2020.

  • EUROTOX in vitro and in silico specialty section webinar "Role of in vitro and in silico methodologies in COVID-19 research", 18/01/2021.

  • FWO-SRN webinar “Modelling and prediction of liver toxicity: focus on drug-induced cholestasis”, 21/01/2021.

  • FWO-SRN webinar “Unraveling distinct immune cell populations and the disturbed gut-liver crosstalk in primary sclerosing cholangitis and related ulcerative colitis”, 27/04/2021.

  • ONTOX webinar “Artificial intelligence”, 14/05/2021.

  • ONTOX webinar “PBPK and QIVIVE”, 21/05/2021.

  • ONTOX webinar “Read-across and QSAR”, 28/05/2021.

  • ONTOX webinar “NGRA”, 11/06/2021.

  • FWO-SRN webinar “Transporter alterations in drug-induced cholestasis”, 01/07/2021.

  • FWO-SRN webinar “Role of Panx1 channel and Cx43 (hemi)channel on murine hepatocarcinogenesis: preliminary data”, 25/10/2021.

  • ONTOX webinar "read-across-based structure-activity relationship", 10/01/2022.

  • FWO-SRN webinar “Bile acid toxicity in cholestatic liver disease”, 12/01/2022.

  • ONTOX webinar “General principles of validation of NAMs”, 14/01/2022.

  • EUROTOX in vitro and in silico specialty section webinar "The use of artificial intelligence in toxicology", 18/01/2022.

  • ONTOX webinar “General principles of REACH legislation”, 21/01/2022.

  • ONTOX webinar “Safety evaluation of cosmetic products”, 28/01/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Adverse outcome pathways", 22/02/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Kidney-based in vitro modelling", 17/03/2022.

  • FWO-SRN webinar “The role of Kupffer cells in chronic liver disease”, 19/04/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Next generation physiologically based kinetic modelling: challenges and opportunities", 25/05/2022.

  • ONTOX webinar “Way forward and future perspectives for NAMs”, 10/06/2022.

  • EUROTOX in vitro and in silico specialty section webinar "QSAR and read-across in the assessment of plant protection products", 14/06/2022.

  • ONTOX webinar “REACH data requirements and upcoming revisions”, 17/06/2022.

  • ONTOX webinar “Current and future challenges of safety evaluation for cosmetics”, 24/06/2022.

  • FWO-SRN webinar “Identification of a novel candidate to promote hepatic maturation in HepG2 cells in vitro​”, 06/07/2022.

  • FWO-SRN webinar “Development of a physiological  map of bile secretion and an adverse outcome pathway of cholestasis​”, 12/10/2022.

  • FWO-SRN webinar “Effects of PFAS on the liver: focus on cholestasis”, 10/01/2023.

  • ONTOX webinar “Intellectual property rights”, 20/01/2023.

  • ONTOX webinar “Intellectual property rights and FAIR principles”, 27/01/2023.

  • FWO-SRN webinar “Serum biomarkers for primary sclerosing cholangitis”, 17/04/2023.

  • FWO-SRN webinar “Role of pannexin1 channels and Cx43 hemichannels in hepatocarcinogenesis and cancer-associated fibroblasts”, 12/06/2023.

  • FWO-SRN webinar “Physiologically-based kinetic modeling of human bile acid handling after administration of bosentan”, 16/10/2023.

  • FWO-SRN webinar “Set-up of an in vitro 3D spheroid co-culture model to predict cholestatic drug-induced liver injury”, 10/01/2024.

  • FWO-SRN webinar "Deubiquitinase UCHL1 targeting as part of new combinatorial treatments for hepatocellular carcinoma", 18/04/2024.

bottom of page